The Regulatory Environment Surrounding Cannabis Medicines in the EU, the USA, and Australia.

ABSTRACT: Background/Objectives: Recent evidence supporting the medicinal use of cannabis has brought significant regulatory changes regarding its legal status, cultivation, and use. Several countries have adopted regulatory strategies enabling access to cannabis-based medicinal products; however, the regulation and availability of high-quality cannabis products differs globally. This work aimed to explore the regulatory pathways available for cannabis-based medicinal products, particularly those regulated as medicines, and establish the current landscape of those approved. Methods: The public repositories of the European Medicines Agency, U.S. Food and Drug Administration, and Therapeutic Goods Administration were searched. A consumer website, Amazon, was searched to provide illustrat

SUBMITTER: Jardim C 

PROVIDER: S-EPMC12115261 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature